Vaccine Storage Equipment Market (2020-2027)

The Vaccine Storage Equipment Market is expected to grow at a CAGR of 10.6% from 2020 to reach $1.83 billion by 2027.

Published
Jan 2021
Pages
185
Format
PDF + Excel
Report ID
MR-464
Base year
2019
Market size · USD billion · 2019–2027Forecast 2020–2027 · 10.6% CAGR
2027 · FORECAST
$1.83B
2027
$1.83B
CAGR 2020–2027
10.6%
$3B$2.25B$1.5B$750M0
2019
2020
'21
'22
'23
'24
'25
'26
'27

2019 baseline · 2020–2027 forecast at 10.6% CAGR · hover a bar for the value

Key highlights

01

The Vaccine Storage Equipment Market is expected to grow at a CAGR of 10.6% from 2020 to reach $1.83 billion by 2027.

02

Distributor end user segment to witness rapid growth during the forecast period

03

North America commanded the largest share of the global vaccine storage equipment market in 2020 and is expected to maintain its dominance throughout the forecast period.

Report summary

ParticularsDetails
Base Year2019
Estimated Year2020
Forecast Period2020–2027
Market Size (2027)USD 1.83 billion
CAGR (2020–2027)10.6%
FormatPDF, Excel & Cloud Portal · 185 pages
Segments CoveredBy Type: Chest Ultra Low Temperature Freezer, Upright Low Temperature Freezer, Chest Low Temperature Freezer, Electric, Solar, Others · By End User: Hospitals and Medical Institutes, Distributors, Others
Countries CoveredEurope (RoE), Asia-Pacific (RoAPAC)
Key CompaniesThermo Fisher Scientific, Inc. (U.S.), B Medical Systems, Eppendorf AG, Cole-Parmer Instrumentation Company, LLC (U.S.), Haier Group Corporation, Philipp Kirsch GmbH, PHC Corporation, Helmer Scientific, Inc. (U.S.), EVERmed S.R.L, Vestfrost Solutions

Report overview

Scope note

Segments covered: type, end user. Regions: Europe, Asia-Pacific.

Vaccines are extremely sensitive in nature and require to be kept at recommended temperature to maintain its efficiency. Purpose-built storage equipment, such as refrigerators and freezers, provides optimum cooling to the vaccines.

The growth in the vaccine storage equipment market is majorly propelled by large scale vaccination programs implemented by the global health agencies (such as WHO, UNICEF, GAVI (Global Alliance for Vaccines and Immunization), Vaccine for Children Program), high incidence of infectious diseases, launch of COVID-19 vaccines, among others. However, high cost of cold storage equipment and stringent vaccine storage requirements are expected to hinder the growth of the vaccine storage equipment market to some extent. In addition, development of highly stable and energy efficient ultra-low temperature freezers, and technology advancements serve as an opportunity for vendors in vaccine storage equipment market.

On March 11, 2020, the World Health Organization declared a global pandemic arising from corona virus disease – 19 (COVID-19). The pandemic triggered a race among leading drug-makers and research institutes to develop a vaccine at the earliest. On December 02, 2020, the U.K. approved covid-19 vaccines co-developed by Pfizer, Inc. (U.S.) and BioNTech. Since then, few other COVID-19 vaccines were approved for emergency use. Further, at least 7.7 billion vaccine doses have been purchased and another 3.9 billion reserved by varied countries and regions (Duke Global Health Innovation Center). These significant volume deliveries required in short duration is expected to create huge demand for vaccine storage equipment globally.

A large number of vaccination programs are run by international organizations as well as local governments across the globe. These programs have created a significant network that manages vaccinations at large scale. Some of the leading global programs include The Global Vaccine Action plan (GVAP), Immunization Program by UNICEF, among others.

Vaccine Storage Equipment Market
Vaccine Storage Equipment Market · Report infographic

Table of contents

12 chapters · 86 sections · 185 pages · click to expand
Review the full research scope before you buy. Chapters can also be purchased individually.

1.1Market definition
1.2Market ecosystem
1.3Currency and limitations
1.3.1Currency
1.3.2Limitations
1.4Key stakeholders

Segmental analysis

SegmentLargest share (2020)Fastest growth (2020–2027)
By End User—Distributors
01

By End User

  • Distributor end user segment to witness rapid growth during the forecast period
  • Distributors segment is rapidly gaining traction and is expected to witness the highest growth, mainly attributed to the urgency and large-scale delivery requirement of COVID-19 vaccines across the globe.
CoversHospitals and Medical InstitutesDistributorsOthers

Geographic analysis

01

North America

Fastest growth

North America commanded the largest share of the global vaccine storage equipment market in 2020 and is expected to maintain its dominance throughout the forecast period. This region is also expected to grow at the highest growth during the forecast period. The large share of this region is mainly attributed to the U.S. and significant volume order placed by the U.S. and Canada for COVID-19 vaccine & vaccine storage equipment. North America: The fastest growing market

Competitive landscape

Companies profiled (10)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • B Medical Systems · Luxembourg
  • Eppendorf AG · Germany
  • Cole-Parmer Instrumentation Company, LLC (U.S.)
  • Haier Group Corporation · China
  • Philipp Kirsch GmbH · Germany
  • PHC Corporation · Japan
  • Helmer Scientific, Inc. (U.S.)
  • EVERmed S.R.L · Italy
  • Vestfrost Solutions · Denmark

Frequently asked questions

The global vaccine storage equipment market is expected to grow at a CAGR of 10.6% from 2020 to reach $1.83 billion by 2027.

Cite this report

Meticulous Research. (2021). Vaccine Storage Equipment Market - Global Opportunity Analysis and Industry Forecast (2020-2027) (Report No. MR-464). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/vaccine-storage-equipment-market-5160

Search Market Intelligence

Search across reports, blogs, press releases, and industries